<DOC>
	<DOCNO>NCT00770510</DOCNO>
	<brief_summary>The purpose study investigate evaluate efficacy Eszopiclone Japanese participant primary insomnia .</brief_summary>
	<brief_title>A Phase II/III Study SEP-190 ( Eszopiclone ) Patients With Primary Insomnia ( Study 190-126 )</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , placebo-controlled , 5-way cross-over study investigate evaluate efficacy eszopiclone Japanese participant primary insomnia . The treatment period consist two consecutive day ( two night ) one term . Patients receive oral eszopiclone ( 1 , 2 , 3 mg ) , zolpidem tartrate ( 10 mg ) , placebo daily bedtime use . Participants randomly assign one 10 prespecified treatment sequence pattern .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>1 . Participants age great equal 21 less 65 year time obtain write informed consent 2 . Participants diagnose primary insomnia base Diagnostic Statistical Manual Mental Disorders , text revision ( DSMIVTR ) Japanese version follow condition persistent equal 4 week start observation period : Sleep latency equal 30 minute equal 3 day week Total sleep time le equal 390 minute equal 3 day week 3 . Participants meet follow base polysomnogram ( PSG ) observation period : Objective sleep latency equal 20 minute 2 consecutive PSG day Objective total sleep time le equal 420 minute 2 consecutive PSG day , objective wake time sleep equal 20 minute 2 consecutive PSG day 1 . Participants comorbid primary sleep disorder ( e.g. , circadian rhythm disorder , restless limb syndrome , periodic limb movement disorder , sleep apnea syndrome ) , primary insomnia . 2 . Participants insomnia caused pharmacological action ( druginduced insomnia ) . 3 . Participants comorbid sleep disorder associate disease ( ) psychiatric and/or physical disease ( ) . 4 . Participants complication psychiatric disorder Axis I personality disorder Axis II define DSMIVTR Japanese version . 5 . Participants organic mental disorder .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Primary insomnia</keyword>
</DOC>